Results..25 Apr 2023 12:52
Alliance News) - Oxford BioMedica PLC on Tuesday reported a drop in annual revenue and swung to a loss, as a result of lower volumes and higher costs.
The Oxfordshire, England-based gene and cell therapy group posted revenue of GBP140.0 million in 2022, down from GBP142.8 million a year ago. It swung to a pretax loss of GBP46.0 million from a profit of GBP19.9 million.
And it’s up nearly 3% ?. Go figure